Provided by EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC)
EORTC has developed a number of tailored tools and skills, enabling effective and qualitative management of increasingly diverse and complex clinical study data.
Clinical Trials tools, imaging tools, Molecular analysis tools, quality of life questionaires
Our databases include information from multiple sources, including clinical, radiotherapy, diagnostic, molecular imaging and biological samples.
Clinical development and regulatory affairs: highly specialized expertise and experience for the conception, preparation and realization of clinical trials, in collaboration with hospital-based investigators, and conform to both French and international regulatory frameworks.
Visit website
• trial management operations (interaction with competent authorities & ethics committees, project management, monitoring, vigilance, data management)
• clinical trial tools (outcome measures, regulatory database, site locations, risk-based monitoring)
C4C Expert Advice service gives you fast and efficient access to over 400 clinical, methodology, and patient and public involvement experts.
Their up-to-date and in-depth insights can provide value at any stage of paediatric drug development but are especially useful to improve study design.
We provide end-to-end support, resulting in high-quality, independent advice reports that can be used in regulatory discussions on PIPs (paediatric investigation plans) and PSPs (paediatric study plans )
Obtain multidisciplinary insights from a single request and a single contract.
A tailored team of experts is assembled for each request.
Improve patient recruitment and retention through making a study more patient-centric based on the insights of children, young people and families.
PedCRIN developed a series of tools (WP3) and procedures to support the setup and the management of multinational neonatal and paediatric clinical trials in Europe. These tools are developed to train and support researchers and clinicians so they can establish, run, and manage both paediatric and neonatal multinational clinical trials in a more effective and easier way. The removal of barriers to trial management will speed up the evaluation of new and improved therapies.
Visit website